Response of aged mice to primary virus infections

Immunological Reviews

Volumn 205, Issue , 2005, Pages 285-296

  Murasko, Donna M ^a   Jiang, Jiu ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENVIRONMENTAL FACTOR; IMMUNE RESPONSE; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

AGING; ANIMALS; HUMANS; MICE; TIME FACTORS; VIRUS DISEASES;

EID: 20344396332     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00273.x     Document Type: Review

References (66)

1. Yoshikawa TT. Important infections in elderly persons. West J Med 1981;135:441-445.
2. Couch RB, et al. Influenza: its control in persons and populations. J Infect Dis 1986;153:431-440.
3. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993;167:584-592.
4. Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J Clin Microbiol 1989;27:2666-2671.
5. Moss P. Cellular immune responses to influenza. Dev Biol (Basel) 2003;115:31-37.
6. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2002;51:1-31.
7. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999;179:25-30.
8. Donnelly CA, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-1766.
9. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001;32:1481-1486.
10. Kao JH, Lai MY, Chen PJ, Hwang LH, Chen W, Chen DS. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis. Am J Gastroenterol 1996;91:506-510.
11. Toh BH, Roberts-Thomson IC, Mathews JD, Whittingham S, Mackay IR. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol 1973;14:193-202.
12. Murasko DM, Weiner P, Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 1987;70:440-448.
13. Gardner EM, Murasko DM. Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology 2002;3:271-290.
14. Chopra RK, Powers DC, Kendig NE, Adler WH, Nagel JE. Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation. Immunol Invest 1989;18:961-973.
15. Chopra RK, Holbrook NJ, Powers DC, McCoy MT, Adler WH, Nagel JE. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and nvRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopathol 1989;53:297-308.
16. Nagelkerken L, Hertogh-Huijbregts A, Dobber R, Drager A. Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells. Eur J Immunol 1991;21:273-281.
17. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150:5219-5130.
18. Hobbs MV, Weigle WO, Ernst DN. Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell Immunol 1994;154:264-272.
19. Burns EA, Lum LG, L'Hommedieu G, Goodwin JS. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. J Gerontol 1993;48:B231-B236.
20. Wang L, Anaraki F, Henion TR, Galili U. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol A Biol Sci Med Sci 1995;50:M227-M233.
21. Bender BS, Small PA. Heterotypic immune mice lose protection against influenza virus infection with senescence. J Infect Dis 1993;168:873-880.
22. Effros RB, Walford RL. The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cell Immunol 1983;81:298-305.
23. Effros RB, Walford RL. Diminished T-cell response to influenza virus in aged mice. Immunology 1983;49:387-392.
24. Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res 1999;44:79-102.
25. Stamboulian D, Bonvehi PE, Nacinovich FM, Cox N. Influenza. Infect Dis Clin North Am 2000;14:141-166.
26. Lin YL, Askonas BA. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981;154:225-234.
27. Bender BS, Johnson MP, Small PA. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 1991;72:514-519.
28. Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM. Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 2002;123:1167-1181.
29. Oldstone MB. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 2002;263:83-117.
30. Khanolkar A, Fuller MJ, Zajac AJ. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res 2002;26:309-321.
31. Kapasi ZF, Murali-Krishna K, McRae ML, Ahmed R. Defective generation but normal maintenance of memory T cells in old mice. Eur J Immunol 2002;32:1567-1573.
32. Cinader B, van der Gaag HC, Koli SY, Axelrad AA. Friend virus replication as a function of age. Mech Ageing Dev 1987;40:181-191.
33. Tumas K, Overmoyer B, Clevenger CV, Blank KJ, Prystowsky MB. Murine leukemia virus infection in immunocompetent adult mice. Virology 1993;192:1-10.
34. Pozsgay JM, Klyczek KK, Blank KJ. In vivo generation of antigenic variants of murine retroviruses. Virology 1989;173:330-334.
35. Avidan N, Tumas-Brundage KM, Sieck TG, Prystowsky MB, Blank KJ. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus. Virology 1995;211:507-515.
36. Panoutsakopoulou V, Little CS, Sieck TG, Blankenhorn EP, Blank KJ. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice. J Immunol 1998;161:17-26.
37. elRefaei M, Blank KJ, Murasko DM. Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response. Virology 2001;290:281-289.
38. Doherty PC. Diminished T cell surveillance function in old mice infected with lymphocyte choriomeningitis virus. Immunology 1977;32:751-754.
39. Bender BS, Taylor SF, Zander DS, Cottey R. Pulmonary immune response of young and aged mice after influenza challenge. J Lab Clin Med 1995;126:169-177.
40. Mathur U, Bentley DW, Hall CB, Roth FK, Douglas RG Jr. Influenza A/Brazil/78(H1N1) infection in the elderly. Am Rev Respir Dis 1981;123:633-635.
41. Kris RM, Yetter RA, Cogliano R, Ramphal R, Small PA. Passive serum antibody causes temporary recovery from influenza virus infection of die nose, trachea and lung of nude mice. Immunology 1988;63:349-353.
42. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-826.
43. Ennis FA, Martin WJ, Verbonitz MW. Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med 1977;146:893-898.
44. Murasko DM, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002;37:427-439.
45. Elrefaei M, Blank KJ, Murasko DM. Decreased IL-2, IFN-gamma, and IL-10 production by aged mice during the acute phase of E55+ retrovirus infection. Virology 2002;299:8-19.
46. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense, function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
47. Kutza J, Kaye D, Murasko DM. Basal natural killer cell activity of young versus elderly humans. J Gerontol A Biol Sci Med Sci 1995;50:B110-B116.
48. Kiessling R, Klein E, Pross H, Wigzell H. 'Natural' killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:117-121.
49. Plett A, Murasko DM. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta. Mech Ageing Dev 2000;112:197-215.
50. Muller U, et al. Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
51. Fiette L, et al. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J Exp Med 1995;181:2069-2076.
52. Murphy JA, Duerst RJ, Smith TJ, Morrison LA. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 2003;77:9337-9345.
53. Samuel CE. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
54. Pfeifer K, Ushijima H, Lorenz B, Muller WE, Schroder HC. Evidence for age-dependent impairment of antiviral 2′,5′-oligoadenylate synthetase/ribonuclease 1-system in tissues of rat. Mech Ageing Dev 1993;67:101-114.
55. Rytel MW. Effect of age on viral infections: possible role of interferon. J Am Geriatr Soc 1987;35:1092-1099.
56. Zhang X, Fujii H, Kishimoto H, LeRoy E, Surh CD, Sprent J. Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J Exp Med 2002;195:283-293.
57. Jiang J, Gross D, Nogusa S, Elbaum P, Murasko DM. Role of IFN-I in depletion of non-specific T cells: differences between young and aged mice. J Immunol 2005;175:
58. Plett PA, Gardner EM, Murasko DM. Age-related changes in interferon-alpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev 2000;118:129-144.
59. Kutza J, Murasko DM. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev 1996;90:209-222.
60. He XS, et al. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 2004;114:1812-1819.
61. Nguyen KB, et al. Coordinated and distinct roles for IFN-αb, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002;169:4279-4287.
62. Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and anti-viral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996;156:1138-1142.
63. Biron CA, Nguyen KB, Pien GC. Innate immune responses to LCMV infections, natural killer cells and cytokines. Curr Top Microbiol Immunol 2002;263:7-27.
64. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol 2001;75:5965-5976.
65. Jiang J, Lau LL, Shen H. Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J Immunol 2003;171:4352-4358.
66. Jiang J, Anaraki F, Blank KJ, Murasko DM. Cutting edge: T cells from aged mice are resistant to depletion early during virus infection. J Immunol 2003;171:3353-3357.